株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血液検査:各種技術と世界の市場

Blood Testing: Technology and Global Markets

発行 BCC Research 商品コード 327448
出版日 ページ情報 英文 168 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
血液検査:各種技術と世界の市場 Blood Testing: Technology and Global Markets
出版日: 2015年03月30日 ページ情報: 英文 168 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

血液検査の市場は2013年に495億ドル、2014年には500億ドルの規模を記録しました。2014年から2019年にかけては2.6%のCAGRで推移し、2019年には566億ドルの規模に成長すると予測されています。

当レポートでは、世界の血液検査の市場について調査し、血液検査のさまざまな目的と検査項目、関連の法規制、新たな開発および市場の発展の動向、検査内容・地域・利用場所など各種区分別の市場収益の推移と予測、市場のリーダーと市場シェア、市場への影響因子の分析、特許動向、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 サマリー

第3章 概要

  • 定義
  • 血液検査の発展の経緯
  • 検査
    • 従来型検査
    • ポイントオブケア検査 (POC検査)
  • 血液検査
  • 診断検査
    • 完全血球算定
    • 赤血球沈降速度 (ESR)
    • 酵素検査
    • 凝固検査
    • 動脈血ガス検査 (ABG検査)
  • スクリーニングパネル
    • スクリーニングテスト
    • 癌スクリーニング血液検査/癌バイオマーカー検査
    • 血液型検査および交差適合試験
    • 蛋白試験
    • 一般毒性・薬物乱用検査
    • 脂質プロファイルまたはコレステロール検査
    • 総合代謝パネル
  • モニタリング検査
    • 遺伝子検査
    • 生化学検査 またはBMP
    • ホルモン検査
  • 血液検査における血液抽出方法
  • 血液検査のメリット
  • 血液検査のデメリット
  • ポイントオブケア検査の技術的展望
    • PCR
    • タンデム型質量分析
    • マイクロアレイ
    • 遺伝子配列決定またはDNA配列決定
    • FISH法

第4章 法規制環境

  • CLIA (臨床検査改善促進法) 適応免除の検査

第5章 新たな開発・発展動向

  • 血液検査・アッセイ・キットの臨床試験
  • M&A
  • 新製品の市場投入
  • 新技術

第6章 市場分析

  • タイプ別市場
    • 市場概要
    • 市場収益
    • 市場シェア
  • 地域別市場
    • 市場概要
    • 市場収益
    • 市場シェア
    • 血液学的検査
      • 市場概要
      • 市場収益
    • 感染症検査
      • 市場概要
      • 市場収益
    • 血液凝固検査
      • 市場概要
      • 市場収益
    • 完全血球算定・総合血液検査・酵素血液検査
      • 市場概要
      • 市場収益
    • 癌の検査 (腫瘍/癌アッセイテスト)
      • 市場概要
      • 市場収益
    • 毒性検査
      • 市場概要
      • 市場収益
    • 心臓プロファイルの検査
      • 市場概要
      • 市場収益
    • 炎症の検査
      • 市場概要
      • 市場収益
    • その他
      • 市場概要
      • 市場収益

第7章 産業構造

  • 血液学
    • 市場のリーダー
    • 市場シェア
  • 心臓
    • 市場シェア
  • 炎症
    • 市場のリーダー
    • 市場シェア
    • 市場のリーダー
    • 市場シェア
  • 毒素
    • 市場のリーダー
    • 市場シェア
  • その他
    • 市場のリーダー
    • 市場シェア

第8章 血液検査市場:利用場所別

  • 血液検査の利用場所別の市場
    • 世界市場:利用場所別
    • 市場シェア
  • 処方/医師オフィス/診療所における血液検査
    • 市場概要
    • 市場収益
    • 市場シェア
    • 癌血液検査
      • 癌バイオマーカー
      • 市場概要
      • 市場収益
  • 血液疾患検査
    • 市場概要
    • 市場収益
  • 自己免疫疾患 ・食物アレルギーの検査
    • 市場概要
    • 市場収益
  • 心血管疾患検査
    • 市場概要
    • 市場収益
  • 腎障害検査
    • 市場概要
    • 市場収益
  • 肝障害検査
    • 市場概要
    • 市場収益
  • 妊娠検査
    • 市場概要
    • 市場収益
  • 糖尿病検査
    • 市場概要
    • 市場収益
  • 受胎能力検査
    • 市場概要
    • 市場収益
  • 家庭用モニタリング検査
    • 市場概要
    • 市場収益
    • 市場シェア
    • 機器
      • 市場概要
      • 市場収益
    • テストストリップ
      • 市場概要
      • 市場収益

第9章 特許分析

  • 年代別
  • タイプ/カテゴリー別
  • 企業別
  • 国別
  • 譲受人別

第10章 現在の状況

  • 血液検査への影響因子
    • 慢性疾患・感染症
    • 高齢化
    • ライフスタイル
    • 肥満
    • 家庭用モニタリングシステム・新製品
    • 製造技術
    • 価格制御
    • 法規制上の圧力
    • 同種の機器
    • ライセンシング契約
    • M&A

第11章 企業プロファイル

  • A. MENARINI DIAGNOSTICS LTD.
  • ABAXIS
  • ABBOTT LABORATORIES
  • AKERS BIOSCIENCES INC. (ABI)
  • ALERE INC.
  • ANDON HEALTH CO. LTD.
  • APEX BIOTECHNOLOGY CORP.
  • ARKRAY USA INC.
  • BAYER HEALTHCARE PHARMACEUTICALS
  • BECTON, DICKINSON AND CO. (BD)
  • BIOMERIEUX MARCY L'ETOILE
  • BIO-RAD LABORATORIES INC.
  • CEPHEID
  • DANAHER CORP.
  • DEXCOM INC.
  • GRIFOLS
  • HEMOSENSE INC.
  • HMD BIOMEDICAL INC.
  • HOFFMAN-LA ROCHE
  • HOLOGIC
  • IDEAL LIFE INC.
  • INFOPIA CO. LTD.
  • JOHNSON & JOHNSON
  • LIFESCAN INC.
  • LUMINEX CORP.
  • MEDTRONIC
  • NIPRO DIAGNOSTICS INC.
  • NOVA BIOMEDICAL CORP.
  • ORTHO CLINICAL DIAGNOSTICS
  • QIAGEN
  • SIEMENS AG
  • T2 BIOSYSTEMS
  • THERMO FISHER SCIENTIFIC INC.
  • TRINITY BIOTECH

第12章 付録

図表

目次
Product Code: HLC184A

REPORT HIGHLIGHTS

The blood testing market totaled $49.5 billion in 2013 and reached to nearly $50 billion in 2014 This market is expected to grow $56.6 billion in 2019, with a compound annual growth rate (CAGR) of 2.6%.

This report provides:

  • An overview of the global markets and technologies for blood testing.
  • Analyses of global market trends, with data from 2012, 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Coverage of major blood test categories including hematology, molecular screening, toxicology, and also oncology biomarker tests and cardiology tests.
  • Information on the latest trends and innovations in the blood testing product pipeline as well as information on new approaches for screening.
  • Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
  • Relevant patent analysis.
  • Profiles of major players in the blood testing market.

SCOPE OF THE STUDY

This study covers the blood tests that are used routinely for screening, monitoring and evaluating by using analyzers (including automated analyzers) and integrated systems. This report also covers home-monitoring devices and test strips and the associated calibration reagents. The report analyzes and assesses therapeutic and screening applications of blood tests for human conditions such as diabetes, heart disease, autoimmune disorders, cancer, blood disorders, hormonal imbalances, infection, and pregnancy. Excluded from this study are urinalysis, urine home diagnostic kits, and diagnostic testing such as imaging. This study also excludes veterinary blood tests and their analyzers.

The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections, and market shares. The emerging markets discussed include countries such as India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, and Canada, among others. The Europe and U.S. markets are also covered.

The report also examines the factors boosting the blood testing market as well as the hindering factors. Further, the pipeline products and companies that are leading the blood test diagnostic market in the research and development of blood tests are discussed.

ANALYSTS' CREDENTIALS

This study has been carried out by a team of professionals in the biotechnology industry. The project manager for this project is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has over 14 years of industry experience. Ms. Dewan was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • CONTRIBUTIONS OF THE STUDY AND FOR WHOM
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYSTS' CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)

CHAPTER 3 - OVERVIEW

  • DEFINITIONS
    • BLOOD TEST
    • ANTIGEN
    • ANTIBODY
    • RED BLOOD CELLS
    • WHITE BLOOD CELLS
    • PLATELETS
    • PLASMA
    • BLOOD GROUP OR BLOOD TYPE
    • BLOOD TRANSFUSION
  • HISTORY OF BLOOD TESTING
    • TABLE 1: EVOLUTION OF BLOOD TRANSFUSION AND BLOOD TESTS
  • TESTING
    • TRADITIONAL TESTING
    • POINT-OF-CARE (POC) TESTING
      • TABLE 2: DIFFERENCES BETWEEN TRADITIONAL (MANUAL) BLOOD TESTING AND POINT-OF-CARE TESTING (AUTOMATIC)
  • BLOOD TESTS
  • DIAGNOSTIC TESTS
    • COMPLETE BLOOD COUNT
      • Total Red Blood Cell Count
      • Total White Blood Cell Count
      • Mean Corpuscular Volume (MCV)
      • Hemoglobin
      • Hematocrit
      • Hemoglobin A1c (HbA1c)
      • Mean Corpuscular Hemoglobin or Mean Corpuscular Hemoglobin Volume
    • COMPLETE BLOOD COUNT WITH DIFFERENTIAL AND PLATELET BLOOD TEST
      • Neutrophil Granulocytes
      • Lymphocytes
      • Monocytes
      • Eosinophil Granulocytes
      • Basophil Granulocytes
      • Platelets
        • TABLE 3: CONDITIONS ASSOCIATED WITH ABNORMALITIES OF ANALYTE OF COMPLETE BLOOD COUNT
    • ERYTHROCYTE SEDIMENTATION RATE (ESR)
    • ENZYME TEST
      • Troponin
      • Creatine Kinase (CK)
      • Lactate Dehydrogenase (LDH)
      • Alanine Transaminase (ALT) and Aspartate Transaminase (AST)
    • CLOTTING TEST OR COAGULATION TEST
      • Hemostasis
      • Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)
      • Factor V Assay
      • Fibrinogen
      • Thrombin Time
    • ARTERIAL BLOOD GAS (ABG) TEST
  • SCREENING PANELS
    • SCREENING TESTS
    • CANCER SCREENING BLOOD TEST/CANCER BIOMARKER TEST
    • BLOOD GROUPING OR CROSS-MATCHING TEST
      • TABLE 4: BLOOD GROUP COMPATIBILITY
      • TABLE 5: PLASMA COMPATIBILITY
    • TOTAL PROTEIN TEST
      • A/G (Albumin/Globulin)
      • Total Bilirubin
    • GENERAL TOXICOLOGY AND DRUG-ABUSE TEST
      • Biomonitoring or Body Burden Test
      • Food Safe Allergy Test/Panel
    • LIPID PROFILE OR CHOLESTEROL TEST
      • Cholesterol Test
        • Cholesterol
      • C-Reactive Protein Test
    • COMPREHENSIVE METABOLIC PANEL
  • MONITORING TESTS
    • GENETIC TEST
    • BIOCHEMICAL TEST OR BASIC METABOLIC PANEL (BMP)
      • Diabetic Profile
      • Fluids and Electrolytes
      • Calcium
      • Kidney Profile
    • HORMONE TEST
  • METHODS OF EXTRACTION OF BLOOD FOR BLOOD TESTING
  • ADVANTAGES OF BLOOD TESTS
  • DISADVANTAGES OF BLOOD TESTS
  • TECHNOLOGY OUTLOOK FOR POINT-OF-CARE TESTING
    • POLYMERASE CHAIN REACTION (PCR)
    • TANDEM MASS SPECTROMETRY
    • MICROARRAY
    • GENE SEQUENCING OR DNA SEQUENCING
    • FLUORESCENCE IN SITU HYBRIDIZATION (FISH)

CHAPTER 4 - REGULATORY ASPECTS

  • CLIA-WAIVED TESTS
    • RECENTLY APPROVED BLOOD TESTS, ASSAYS, KITS, AND DEVICES
      • TABLE 6: RECENT APPROVALS OF BLOOD TESTS, ASSAYS, KITS, AND MEDICAL DEVICES, 2010 TO SEPTEMBER 2014
    • RECENT APPROVALS OF MEDICAL DEVICES CLEARED THROUGH 510(K)
      • TABLE 7: RECENT APPROVALS OF MEDICAL DEVICES CLEARED THROUGH 510(K), 2010 TO SEPTEMBER 2014
    • APPROVALS OF CLIA-WAIVED BLOOD TESTS
      • TABLE 8: APPROVALS OF CLIA-WAIVED BLOOD TESTS, 2010 TO SEPTEMBER 2014
    • RECALLS
      • TABLE 9: RECALLS,2010 TO SEPTEMBER 2014
    • SAFETY ALERTS
      • TABLE 10: SAFETY ALERTS, 2010 TO SEPTEMBER 2014

CHAPTER 5 - NEW DEVELOPMENTS

  • CLINICAL TRIALS OF BLOOD TESTS, ASSAYS AND KITS
    • TABLE 11: CLINICAL TRIALS IN BLOOD TESTS, ASSAYS AND KITS, 2010 TO SEPTEMBER 2014
  • MERGERS AND ACQUISITIONS
    • TABLE 12: MERGERS AND ACQUISITIONS OF TOP PHARMACEUTICAL COMPANIES, 2010 TO SEPTEMBER 2014
  • NEW PRODUCT LAUNCHES
    • TABLE 13: NEW PRODUCT LAUNCHES, 2012 TO SEPTEMBER 2014
  • NEW TECHNOLOGIES

CHAPTER 6 - MARKET ANALYSIS

  • MARKET BY TYPE
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 14: GLOBAL REVENUE FOR BLOOD TESTS BY TYPE, THROUGH 2019
      • FIGURE 1: GLOBAL REVENUE FOR BLOOD TESTS BY TYPE, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 15: MARKET SHARE OF BLOOD TESTS BY TYPE, 2013 (%)
      • FIGURE 2: MARKET SHARE OF BLOOD TESTS BY TYPE, 2013 (%)
  • MARKET BY REGION
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 16: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 3: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 17: MARKET SHARE OF BLOOD TESTS BY REGION, 2013 (%)
      • FIGURE 4: MARKET SHARE OF BLOOD TESTS BY REGION, 2013 (%)
    • HEMATOLOGY BLOOD TESTS
      • Market Overview
      • Market Revenue
        • TABLE 18: GLOBAL REVENUE FOR HEMATOLOGY BLOOD TESTS BY TYPE, THROUGH 2019 ($ MILLIONS)
        • FIGURE 5: GLOBAL REVENUE FOR HEMATOLOGY BLOOD TESTS BY TYPE, 2012-2019 ($ MILLIONS)
    • Infectious Blood Tests
      • Market Overview
      • Market Revenue
        • TABLE 19: GLOBAL REVENUE FOR INFECTIOUS BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 6: GLOBAL REVENUE FOR INFECTIOUS BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • Blood Clotting Tests
      • Market Overview
      • Market Revenue
        • TABLE 20: GLOBAL REVENUE FOR BLOOD CLOTTING TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 7: GLOBAL REVENUE FOR BLOOD CLOTTING TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • Complete Blood Count, Comprehensive Blood Tests, and Enzyme Blood Tests
      • Market Overview
      • Market Revenue
        • TABLE 21: GLOBAL REVENUE FOR COMPLETE BLOOD COUNT, COMPREHENSIVE BLOOD TESTS, AND ENZYME BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 8: GLOBAL REVENUE FOR COMPLETE BLOOD COUNT, COMPREHENSIVE BLOOD TESTS, AND ENZYME BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • ONCOLOGY BLOOD TESTS (TUMOR/CANCER ASSAY TESTS)
      • Market Overview
      • Market Revenue
        • TABLE 22: GLOBAL REVENUE FOR CANCER/TUMOR ASSAY TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 9: GLOBAL REVENUE FOR CANCER/TUMOR ASSAY TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • TOXICOLOGY BLOOD TESTS
      • Market Overview
      • Market Revenue
        • TABLE 23: GLOBAL REVENUE FOR TOXICOLOGY TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 10: GLOBAL REVENUE FOR TOXICOLOGY TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • HEART PROFILE BLOOD TESTS
      • Market Overview
      • Market Revenue
        • TABLE 24: GLOBAL REVENUE FOR HEART PROFILE BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 11: GLOBAL REVENUE FOR HEART PROFILE BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • INFLAMMATION BLOOD TESTS
      • Market Overview
      • Market Revenue
        • TABLE 25: GLOBAL REVENUE FOR INFLAMMATION BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 12: GLOBAL REVENUE FOR INFLAMMATION BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • OTHERS CATEGORY OF BLOOD TESTS
      • Market Overview
      • Market Revenue
        • TABLE 26: GLOBAL REVENUE FOR OTHER BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 13: GLOBAL REVENUE FOR OTHER BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)

CHAPTER 7 - INDUSTRY STRUCTURE

  • HEMATOLOGY
    • MARKET LEADERS
      • TABLE 27: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN HEMATOLOGY BLOOD TESTING, 2013
  • MARKET SHARE
    • TABLE 28: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEMATOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 14: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEMATOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
  • HEART PROFILE
    • MARKET LEADERS
      • TABLE 29: LEADING MANUFACTURERS/ SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN HEART PROFILE BLOOD TESTING, 2013
    • MARKET SHARE
      • TABLE 30: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEART PROFILE BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013
      • FIGURE 15: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEART PROFILE BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
  • INFLAMMATION
    • MARKET LEADERS
      • TABLE 31: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN INFLAMMATION BLOOD TESTING, 2013
  • MARKET SHARE
    • TABLE 32: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF INFLAMMATION BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 16: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF INFLAMMATION BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
  • ONCOLOGY
    • MARKET LEADERS
      • TABLE 33: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN ONCOLOGY BLOOD TESTING, 2013
    • MARKET SHARE
      • TABLE 34: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF ONCOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
      • FIGURE 17: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF ONCOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
  • TOXICOLOGY
    • MARKET LEADERS
      • TABLE 35: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN TOXICOLOGY BLOOD TESTING, 2013
    • MARKET SHARE
      • TABLE 36: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF TOXICOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013
      • FIGURE 18: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF TOXICOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
  • OTHERS CATEGORY
    • MARKET LEADERS
      • TABLE 37: LEADING MANUFACTURERS/SUPPLIERS OF DEVICES, TEST STRIPS, AND ASSAYS IN OTHERS CATEGORY OF BLOOD TESTING, 2013
    • MARKET SHARE
      • TABLE 38: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THE OTHERS CATEGORY OF BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
      • FIGURE 19: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THE OTHERS CATEGORY OF BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)

CHAPTER 8 - MARKET BY APPLICATION

  • BLOOD TESTS BY APPLICATION
    • GLOBAL BLOOD TESTING MARKET BY APPLICATION
      • TABLE 39: GLOBAL REVENUE FOR BLOOD TESTS BY APPLICATION AND END USER, THROUGH 2019 ($ MILLIONS)
      • FIGURE 20: GLOBAL REVENUE FOR BLOOD TESTS BY APPLICATION AND END USER, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 40: MARKET SHARE OF BLOOD TESTS BY APPLICATION AND END USER, 2013 (%)
      • FIGURE 21: MARKET SHARE OF BLOOD TESTS BY APPLICATION AND END USER, 2013 (%)
  • PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 41: GLOBAL REVENUE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, THROUGH 2019 ($ MILLIONS)
      • FIGURE 22: GLOBAL REVENUE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 42: MARKET SHARE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2013 (%)
      • FIGURE 23: MARKET SHARE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2013 (%)
    • CANCER BLOOD TESTING
      • TABLE 43: DIFFERENT KINDS OF CANCER
      • Cancer Biomarker
        • TABLE 44: CANCER BIOMARKERS
      • Market Overview
      • Market Revenue
        • TABLE 45: GLOBAL REVENUE FOR CANCER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 24: GLOBAL REVENUE FOR CANCER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • BLOOD DISORDER BLOOD TESTING
    • TABLE 46: BLOOD DISORDERS
    • Market Overview
    • Market Revenue
      • TABLE 47: GLOBAL REVENUE FOR BLOOD DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 25: GLOBAL REVENUE FOR BLOOD DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • AUTOIMMUNE DISEASE AND FOOD ALLERGY TESTING
    • TABLE 48: AUTOIMMUNE DISEASES
    • Market Overview
    • Market Revenue
      • TABLE 49: GLOBAL REVENUE FOR AUTOIMMUNE DISEASE BLOOD TESTING AND FOOD ALLERGY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 26: GLOBAL REVENUE FOR AUTOIMMUNE DISEASE BLOOD TESTING AND FOOD ALLERGY BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • CARDIOVASCULAR DISEASE BLOOD TESTING
    • TABLE 50: CARDIOVASCULAR DISEASES
    • Market Overview
    • Market Revenue
      • TABLE 51: GLOBAL REVENUE FOR CARDIOVASCULAR DISEASE BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 27: GLOBAL REVENUE FOR CARDIOVASCULAR DISEASE BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • KIDNEY DISORDER BLOOD TESTING
    • TABLE 52: KIDNEY DISORDERS
    • Market Overview
    • Market Revenue
      • TABLE 53: GLOBAL REVENUE FOR KIDNEY DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 28: GLOBAL REVENUE FOR KIDNEY DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • LIVER DISORDER BLOOD TESTING
    • Market Overview
    • Market Revenue
      • TABLE 54: GLOBAL REVENUE FOR LIVER DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 29: GLOBAL REVENUE FOR LIVER DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • PREGNANCY BLOOD TESTING
    • TABLE 55: INFECTIONS CAUSED BY MICROORGANISMS
    • Market Overview
    • Market Revenue
      • TABLE 56: GLOBAL REVENUE FOR PREGNANCY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 30: GLOBAL REVENUE FOR PREGNANCY BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • DIABETES BLOOD TESTING
    • TABLE 57: TYPES OF DIABETES
    • Market Overview
    • Market Revenue
      • TABLE 58: GLOBAL REVENUE FOR DIABETES BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 31: GLOBAL REVENUE FOR DIABETES BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
  • FERTILITY BLOOD TESTING
    • Market Overview
    • Market Revenue
      • TABLE 59: GLOBAL REVENUE FOR FERTILITY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 32: GLOBAL REVENUE FOR FERTILITY BLOOD TESTS, BY REGION, 2012-2019 ($ MILLIONS)
  • HOME-MONITORING BLOOD TESTING
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 60: GLOBAL REVENUE FOR HOME-MONITORING BLOOD TESTING, THROUGH 2019 ($ MILLIONS)
      • FIGURE 33: GLOBAL REVENUE FOR HOME-MONITORING BLOOD TESTING, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 61: MARKET SHARE OF HOME-MONITORING BLOOD TESTING, 2013 (%)
      • FIGURE 34: MARKET SHARE OF HOME-MONITORING BLOOD TESTING, 2013 (%)
    • DEVICES
      • TABLE 62: HOME-MONITORING DEVICES
      • Market Overview
      • Market Revenue
        • TABLE 63: GLOBAL REVENUE FOR HOME-MONITORING DEVICES BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 35: GLOBAL REVENUE FOR HOME-MONITORING DEVICES BY REGION, 2012-2019 ($ MILLIONS)
    • TEST STRIPS
      • Market Overview
      • Market Revenue
        • TABLE 64: GLOBAL REVENUE FOR HOME-MONITORING TEST STRIPS BY REGION, THROUGH 2019 ($ MILLIONS)
        • FIGURE 36: GLOBAL REVENUE FOR HOME-MONITORING TEST STRIPS BY REGION, 2012-2019 ($ MILLIONS)

CHAPTER 9 - PATENT ANALYSIS

  • PATENTS BY YEAR
    • TABLE 65: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • FIGURE 37: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
  • PATENTS BY TYPE/CATEGORY
    • TABLE 66: NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • FIGURE 38: NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
  • PATENTS BY COMPANY
    • TABLE 67: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
  • PATENTS BY COUNTRY
    • TABLE 68: NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • TABLE 69: PATENT SHARES BY COUNTRY, JANUARY 2010 TO SEPTEMBER 2014 (%)
  • PATENTS BY ASSIGNEE
    • TABLE 70: NUMBER OF U.S. PATENTS BY ASSIGNEE, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • FIGURE 39: NUMBER OF U.S. PATENTS BY ASSIGNEE, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)

CHAPTER 10 - CURRENT SITUATION

  • FACTORS AFFECTING BLOOD TESTING
    • THE IMPACT OF CHRONIC DISEASES AND INFECTIONS
    • THE IMPACT OF THE AGING POPULATION
    • THE IMPACT OF LIFESTYLE
    • THE IMPACT OF OBESITY
    • THE IMPACT OF HOME-MONITORING SYSTEMS AND NEW PRODUCTS
    • THE IMPACT OF MANUFACTURING TECHNOLOGIES
    • THE IMPACT OF PRICE CONTROLS
    • THE IMPACT OF REGULATORY PRESSURES
    • THE IMPACT OF SIMILAR DEVICES
    • THE IMPACT OF LICENSING AGREEMENTS
    • THE IMPACT OF MERGERS AND ACQUISITIONS

CHAPTER 11 - COMPANY PROFILES

  • A. MENARINI DIAGNOSTICS LTD.
  • ABAXIS
  • ABBOTT LABORATORIES
  • AKERS BIOSCIENCES INC. (ABI)
  • ALERE INC.
  • ANDON HEALTH CO. LTD.
  • APEX BIOTECHNOLOGY CORP.
  • ARKRAY USA INC.
  • BAYER HEALTHCARE PHARMACEUTICALS
  • BECTON, DICKINSON AND CO. (BD)
  • BIOMERIEUX MARCY L'ETOILE
  • BIO-RAD LABORATORIES INC.
  • CEPHEID
  • DANAHER CORP.
  • DEXCOM INC.
  • GRIFOLS
  • HEMOSENSE INC.
  • HMD BIOMEDICAL INC.
  • HOFFMAN-LA ROCHE
  • HOLOGIC
  • IDEAL LIFE INC.
  • INFOPIA CO. LTD.
  • JOHNSON & JOHNSON
  • LIFESCAN INC.
  • LUMINEX CORP.
  • MEDTRONIC
  • NIPRO DIAGNOSTICS INC.
  • NOVA BIOMEDICAL CORP.
  • ORTHO CLINICAL DIAGNOSTICS
  • QIAGEN
  • SIEMENS AG
  • T2 BIOSYSTEMS
  • THERMO FISHER SCIENTIFIC INC.
  • TRINITY BIOTECH

CHAPTER 12 - APPENDIX-ABBREVIATIONS

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 1: EVOLUTION OF BLOOD TRANSFUSION AND BLOOD TESTS
    • TABLE 2: DIFFERENCES BETWEEN TRADITIONAL (MANUAL) BLOOD TESTING AND POINT-OF-CARE TESTING (AUTOMATIC)
    • TABLE 3: CONDITIONS ASSOCIATED WITH ABNORMALITIES OF ANALYTE OF COMPLETE BLOOD COUNT
    • TABLE 4: BLOOD GROUP COMPATIBILITY
    • TABLE 5: PLASMA COMPATIBILITY
    • TABLE 6: RECENT APPROVALS OF BLOOD TESTS, ASSAYS, KITS, AND MEDICAL DEVICES, 2010 TO SEPTEMBER 2014
    • TABLE 7: RECENT APPROVALS OF MEDICAL DEVICES CLEARED THROUGH 510(K), 2010 TO SEPTEMBER 2014
    • TABLE 8: APPROVALS OF CLIA-WAIVED BLOOD TESTS, 2010 TO SEPTEMBER 2014
    • TABLE 9: RECALLS,2010 TO SEPTEMBER 2014
    • TABLE 10: SAFETY ALERTS, 2010 TO SEPTEMBER 2014
    • TABLE 11: CLINICAL TRIALS IN BLOOD TESTS, ASSAYS AND KITS, 2010 TO SEPTEMBER 2014
    • TABLE 12: MERGERS AND ACQUISITIONS OF TOP PHARMACEUTICAL COMPANIES, 2010 TO SEPTEMBER 2014
    • TABLE 13: NEW PRODUCT LAUNCHES, 2012 TO SEPTEMBER 2014
    • TABLE 14: GLOBAL REVENUE FOR BLOOD TESTS BY TYPE, THROUGH 2019
    • TABLE 15: MARKET SHARE OF BLOOD TESTS BY TYPE, 2013 (%)
    • TABLE 16: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 17: MARKET SHARE OF BLOOD TESTS BY REGION, 2013 (%)
    • TABLE 18: GLOBAL REVENUE FOR HEMATOLOGY BLOOD TESTS BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 19: GLOBAL REVENUE FOR INFECTIOUS BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 20: GLOBAL REVENUE FOR BLOOD CLOTTING TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 21: GLOBAL REVENUE FOR COMPLETE BLOOD COUNT, COMPREHENSIVE BLOOD TESTS, AND ENZYME BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 22: GLOBAL REVENUE FOR CANCER/TUMOR ASSAY TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 23: GLOBAL REVENUE FOR TOXICOLOGY TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 24: GLOBAL REVENUE FOR HEART PROFILE BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 25: GLOBAL REVENUE FOR INFLAMMATION BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 26: GLOBAL REVENUE FOR OTHER BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 27: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN HEMATOLOGY BLOOD TESTING, 2013
    • TABLE 28: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEMATOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • TABLE 29: LEADING MANUFACTURERS/ SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN HEART PROFILE BLOOD TESTING, 2013
    • TABLE 30: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEART PROFILE BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013
    • TABLE 31: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN INFLAMMATION BLOOD TESTING, 2013
    • TABLE 32: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF INFLAMMATION BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • TABLE 33: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN ONCOLOGY BLOOD TESTING, 2013
    • TABLE 34: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF ONCOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • TABLE 35: LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN TOXICOLOGY BLOOD TESTING, 2013
    • TABLE 36: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF TOXICOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013
    • TABLE 37: LEADING MANUFACTURERS/SUPPLIERS OF DEVICES, TEST STRIPS, AND ASSAYS IN OTHERS CATEGORY OF BLOOD TESTING, 2013
    • TABLE 38: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THE OTHERS CATEGORY OF BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • TABLE 39: GLOBAL REVENUE FOR BLOOD TESTS BY APPLICATION AND END USER, THROUGH 2019 ($ MILLIONS)
    • TABLE 40: MARKET SHARE OF BLOOD TESTS BY APPLICATION AND END USER, 2013 (%)
    • TABLE 41: GLOBAL REVENUE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, THROUGH 2019 ($ MILLIONS)
    • TABLE 42: MARKET SHARE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2013 (%)
    • TABLE 43: DIFFERENT KINDS OF CANCER
    • TABLE 44: CANCER BIOMARKERS
    • TABLE 45: GLOBAL REVENUE FOR CANCER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 46: BLOOD DISORDERS
    • TABLE 47: GLOBAL REVENUE FOR BLOOD DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 48: AUTOIMMUNE DISEASES
    • TABLE 49: GLOBAL REVENUE FOR AUTOIMMUNE DISEASE BLOOD TESTING AND FOOD ALLERGY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 50: CARDIOVASCULAR DISEASES
    • TABLE 51: GLOBAL REVENUE FOR CARDIOVASCULAR DISEASE BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 52: KIDNEY DISORDERS
    • TABLE 53: GLOBAL REVENUE FOR KIDNEY DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 54: GLOBAL REVENUE FOR LIVER DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 55: INFECTIONS CAUSED BY MICROORGANISMS
    • TABLE 56: GLOBAL REVENUE FOR PREGNANCY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 57: TYPES OF DIABETES
    • TABLE 58: GLOBAL REVENUE FOR DIABETES BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 59: GLOBAL REVENUE FOR FERTILITY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 60: GLOBAL REVENUE FOR HOME-MONITORING BLOOD TESTING, THROUGH 2019 ($ MILLIONS)
    • TABLE 61: MARKET SHARE OF HOME-MONITORING BLOOD TESTING, 2013 (%)
    • TABLE 62: HOME-MONITORING DEVICES
    • TABLE 63: GLOBAL REVENUE FOR HOME-MONITORING DEVICES BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 64: GLOBAL REVENUE FOR HOME-MONITORING TEST STRIPS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 65: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • TABLE 66: NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • TABLE 67: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • TABLE 68: NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • TABLE 69: PATENT SHARES BY COUNTRY, JANUARY 2010 TO SEPTEMBER 2014 (%)
    • TABLE 70: NUMBER OF U.S. PATENTS BY ASSIGNEE, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 1: GLOBAL REVENUE FOR BLOOD TESTS BY TYPE, 2012-2019 ($ MILLIONS)
    • FIGURE 2: MARKET SHARE OF BLOOD TESTS BY TYPE, 2013 (%)
    • FIGURE 3: GLOBAL REVENUE FOR BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 4: MARKET SHARE OF BLOOD TESTS BY REGION, 2013 (%)
    • FIGURE 5: GLOBAL REVENUE FOR HEMATOLOGY BLOOD TESTS BY TYPE, 2012-2019 ($ MILLIONS)
    • FIGURE 6: GLOBAL REVENUE FOR INFECTIOUS BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 7: GLOBAL REVENUE FOR BLOOD CLOTTING TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 8: GLOBAL REVENUE FOR COMPLETE BLOOD COUNT, COMPREHENSIVE BLOOD TESTS, AND ENZYME BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 9: GLOBAL REVENUE FOR CANCER/TUMOR ASSAY TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 10: GLOBAL REVENUE FOR TOXICOLOGY TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 11: GLOBAL REVENUE FOR HEART PROFILE BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 12: GLOBAL REVENUE FOR INFLAMMATION BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 13: GLOBAL REVENUE FOR OTHER BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 14: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEMATOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 15: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEART PROFILE BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 16: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF INFLAMMATION BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 17: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF ONCOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 18: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF TOXICOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 19: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THE OTHERS CATEGORY OF BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
    • FIGURE 20: GLOBAL REVENUE FOR BLOOD TESTS BY APPLICATION AND END USER, 2012-2019 ($ MILLIONS)
    • FIGURE 21: MARKET SHARE OF BLOOD TESTS BY APPLICATION AND END USER, 2013 (%)
    • FIGURE 22: GLOBAL REVENUE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2012-2019 ($ MILLIONS)
    • FIGURE 23: MARKET SHARE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2013 (%)
    • FIGURE 24: GLOBAL REVENUE FOR CANCER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 25: GLOBAL REVENUE FOR BLOOD DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 26: GLOBAL REVENUE FOR AUTOIMMUNE DISEASE BLOOD TESTING AND FOOD ALLERGY BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 27: GLOBAL REVENUE FOR CARDIOVASCULAR DISEASE BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 28: GLOBAL REVENUE FOR KIDNEY DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 29: GLOBAL REVENUE FOR LIVER DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 30: GLOBAL REVENUE FOR PREGNANCY BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 31: GLOBAL REVENUE FOR DIABETES BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 32: GLOBAL REVENUE FOR FERTILITY BLOOD TESTS, BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 33: GLOBAL REVENUE FOR HOME-MONITORING BLOOD TESTING, 2012-2019 ($ MILLIONS)
    • FIGURE 34: MARKET SHARE OF HOME-MONITORING BLOOD TESTING, 2013 (%)
    • FIGURE 35: GLOBAL REVENUE FOR HOME-MONITORING DEVICES BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 36: GLOBAL REVENUE FOR HOME-MONITORING TEST STRIPS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 37: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • FIGURE 38: NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
    • FIGURE 39: NUMBER OF U.S. PATENTS BY ASSIGNEE, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
Back to Top